Department of Justice 2020 – Federal Register Recent Federal Regulation Documents

Results 351 - 400 of 507
Sunshine Act Meeting
Document Number: 2020-05458
Type: Notice
Date: 2020-03-16
Agency: Foreign Claims Settlement Commission, Department of Justice
Registration and Reregistration Fees for Controlled Substance and List I Chemical Registrants
Document Number: 2020-05159
Type: Proposed Rule
Date: 2020-03-16
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration proposes adjusting the fee schedule for registration and reregistration fees necessary to recover the costs of its Diversion Control Program relating to the registration and control of the manufacture, distribution, dispensing, importation and exportation of controlled substances and list I chemicals as mandated by the Controlled Substances Act.
Announcement of Department of Justice Portal for Guidance Documents
Document Number: 2020-05204
Type: Notice
Date: 2020-03-13
Agency: Department of Justice
The Department of Justice is providing public notice of the launch of its portal for guidance documents as directed by Executive Order 13891 ``Promoting the Rule of Law Through Improved Agency Guidance Documents.''
Agency Information Collection Activities; Proposed Collection Comments Requested; Reinstatement, With Change, of a Previously Approved Collection for Which Approval Has Expired: 2020 Law Enforcement Administrative and Management Statistics (LEMAS) Survey
Document Number: 2020-05151
Type: Notice
Date: 2020-03-13
Agency: Department of Justice
The Department of Justice (DOJ), Office of Justice Programs, Bureau of Justice Statistics, will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Schedules of Controlled Substances: Placement of Cenobamate in Schedule V
Document Number: 2020-04963
Type: Rule
Date: 2020-03-10
Agency: Drug Enforcement Administration, Department of Justice
On November 21, 2019, the U.S. Food and Drug Administration (FDA) approved a new drug application for XCOPRI (cenobamate) tablets. Cenobamate is chemically known as [(1R)-1-(2-chlorophenyl)-2-(tetrazol- 2-yl)ethyl] carbamate. Thereafter, the Department of Health and Human Services provided the Drug Enforcement Administration (DEA) with a scheduling recommendation to place cenobamate in schedule V of the Controlled Substances Act (CSA). In accordance with the CSA, as revised by the Improving Regulatory Transparency for New Medical Therapies Act, DEA is hereby issuing an interim final rule placing cenobamate, including its salts, in schedule V of the CSA.
Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension Without Change of a Currently Approved Collection; Notice of Firearms Manufactured or Imported-ATF Form 2 (5320.2)
Document Number: 2020-04890
Type: Notice
Date: 2020-03-10
Agency: Department of Justice, Bureau of Alcohol, Tobacco, Firearms and Explosives
The Department of Justice (DOJ), Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF), will submit the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension Without Change of a Currently Approved Collection; Supplemental Information on Water Quality Considerations-ATF Form 5000.30
Document Number: 2020-04889
Type: Notice
Date: 2020-03-10
Agency: Department of Justice, Bureau of Alcohol, Tobacco, Firearms and Explosives
The Department of Justice (DOJ), Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF), will submit the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension Without Change of a Currently Approved Collection Records of Acquisition and Disposition, Collectors of Firearms
Document Number: 2020-04888
Type: Notice
Date: 2020-03-10
Agency: Department of Justice, Bureau of Alcohol, Tobacco, Firearms and Explosives
The Department of Justice (DOJ), Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF), will submit the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension Without Change of a Currently Approved Collection; Application for Registration of Firearms Acquired by Certain Governmental Entities-ATF F 10 (5320.10)
Document Number: 2020-04887
Type: Notice
Date: 2020-03-10
Agency: Department of Justice, Bureau of Alcohol, Tobacco, Firearms and Explosives
The Department of Justice (DOJ), Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF), will submit the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
William S. Husel, D.O.; Decision and Order
Document Number: 2020-04837
Type: Notice
Date: 2020-03-10
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Johnson Matthey Inc.
Document Number: 2020-04836
Type: Notice
Date: 2020-03-10
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Caligor Pharma Services
Document Number: 2020-04835
Type: Notice
Date: 2020-03-10
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: SpecGx LLC
Document Number: 2020-04834
Type: Notice
Date: 2020-03-10
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Arizona Department of Corrections
Document Number: 2020-04833
Type: Notice
Date: 2020-03-10
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Siemens Healthcare Diagnostics Inc.
Document Number: 2020-04832
Type: Notice
Date: 2020-03-10
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research
Document Number: 2020-04831
Type: Notice
Date: 2020-03-10
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: S&B Pharma, Inc.; Correction
Document Number: 2020-04829
Type: Notice
Date: 2020-03-10
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) published a document in the Federal Register on November 22, 2019, concerning a notice of application. As that document correctly indicated, the applicant, S&B Pharma, Inc., DBA Norac Pharma, 405 South Motor Avenue, Azusa, California 91702-3232 applied to be registered as a bulk manufacturer of a number of controlled substances, to include applying for authorization in order to synthetically manufacture using drug code 7360 (marihuana). However, on the notice of application published, drug code 7360 was inadvertently identified and listed as Gamma Hydroxybutyric Acid instead of Marihuana.
DNA-Sample Collection From Immigration Detainees
Document Number: 2020-04256
Type: Rule
Date: 2020-03-09
Agency: Department of Justice
The Department of Justice is amending regulations that require DNA-sample collection from individuals who are arrested, facing charges, or convicted, and from non-United States persons who are detained under the authority of the United States. The amendment removes a provision authorizing the Secretary of Homeland Security to exempt from the sample-collection requirement certain aliens from whom collection of DNA samples is not feasible because of operational exigencies or resource limitations. This restores the Attorney General's plenary legal authority to authorize and direct all relevant Federal agencies, including the Department of Homeland Security, to collect DNA samples from individuals who are arrested, facing charges, or convicted, and from non-United States persons who are detained under the authority of the United States.
Agency Information Collection Activities: Proposed Collection; Comments Requested; Extension, With Change, of a Previously Approved Collection: Firearm Inquiry Statistics (FIST) Program
Document Number: 2020-04500
Type: Notice
Date: 2020-03-05
Agency: Department of Justice
The Department of Justice (DOJ), Office of Justice Programs, Bureau of Justice Statistics, will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Clarifying Lawful Overseas Use of Data Act; Attorney General Certification and Determination
Document Number: 2020-04248
Type: Notice
Date: 2020-03-03
Agency: Department of Justice
In accordance with the Clarifying Lawful Overseas Use of Data Act (``CLOUD Act''), relating to an executive agreement governing access by a foreign government to electronic data, notice is given that the Attorney General has determined, and has submitted a written certification of such determination to Congress, that the U.S.-U.K. CLOUD Agreement satisfies the requirements of the CLOUD Act.
Notice of Proposed Consent Decree Under the Clean Air Act
Document Number: 2020-04162
Type: Notice
Date: 2020-03-02
Agency: Department of Justice
Agency Information Collection Activities; Proposed eCollection eComments Requested; New Collection
Document Number: 2020-04149
Type: Notice
Date: 2020-03-02
Agency: Department of Justice
The Department of Justice, Civil Rights Division, is submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Notice of Lodging Proposed Consent Decree
Document Number: 2020-04079
Type: Notice
Date: 2020-02-28
Agency: Department of Justice
Executive Office for Immigration Review; Fee Review
Document Number: 2020-03784
Type: Proposed Rule
Date: 2020-02-28
Agency: Executive Office for Immigration Review, Department of Justice
The Department of Justice's Executive Office for Immigration Review (``EOIR'') imposes fees, also known as user charges, for the filing of certain EOIR forms for applications for relief, appeals filed with the Board of Immigration Appeals (``BIA''), and motions to reopen or reconsider. When applicable, the current fee for EOIR applications for relief is $100, and the fee for motions or appeals is $110. EOIR last reviewed and updated these fees 33 years ago, in 1986. This proposed rule (``proposed rule'' or ``rule'') would increase the fees for those EOIR applications, appeals, and motions that are subject to an EOIR-determined fee, based on a fee review conducted by EOIR. This proposed rule would not affect the fees that have been established by the Department of Homeland Security (``DHS'') with respect to DHS forms for applications that are filed or submitted in EOIR proceedings. This proposal does not affect the ability of aliens to submit fee waiver requests, nor does it add new fees. The proposed rule also updates cross-references to DHS regulations regarding fees and makes a technical change regarding requests under the Freedom of Information Act.
Notice Pursuant to the National Cooperative Research and Production Act of 1993-Chede-8
Document Number: 2020-03998
Type: Notice
Date: 2020-02-27
Agency: Antitrust Division, Department of Justice
Registration Requirements for Narcotic Treatment Programs With Mobile Components
Document Number: 2020-03627
Type: Proposed Rule
Date: 2020-02-26
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) proposes to revise the existing regulations for narcotic treatment programs (NTPs) to allow a mobile component associated with the registered program to be considered a coincident activity. The NTP registrants that operate or wish to operate mobile components (in the state that the registrant is registered in) to dispense narcotic drugs in schedules II-V at a remote location for the purpose of maintenance or detoxification treatment would not be required to obtain a separate registration for a mobile component. This proposed rule would waive the requirement of a separate registration at each principal place of business or professional practice where controlled substances are dispensed for those NTPs with mobile components that fully comply with the requirements of the proposed rule, once finalized. These revisions to the regulations are intended to make maintenance or detoxification treatments more widely available, while ensuring that safeguards are in place to reduce the likelihood of diversion.
Jaime C. David, M.D.; Decision and Order
Document Number: 2020-03626
Type: Notice
Date: 2020-02-24
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturers of Marihuana: Irvine Labs, Inc.
Document Number: 2020-03623
Type: Notice
Date: 2020-02-24
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic classes of controlled substances listed in schedule I. Prior to making decisions on this and other pending applications, DEA intends to promulgate regulations that govern the program of growing marihuana for scientific and medical research under DEA registration.
Importer of Controlled Substances Application: PerkinElmer, Inc.
Document Number: 2020-03620
Type: Notice
Date: 2020-02-24
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Research Triangle Institute
Document Number: 2020-03619
Type: Notice
Date: 2020-02-24
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Stepan Company
Document Number: 2020-03618
Type: Notice
Date: 2020-02-24
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Patheon Pharmaceuticals, Inc.
Document Number: 2020-03617
Type: Notice
Date: 2020-02-24
Agency: Drug Enforcement Administration, Department of Justice